IBONYSEPharmaceutical PreparationsFiscal year ends December 31
IMPACT BIOMEDICAL INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$3.06+0.38 (+14.18%)
Close on Oct 19, 2026
- Market cap
- $329.93M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Impact Biomedical's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 6 sales
Net sold $59.45K
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Frank D. Heuszel | Chief Executive Officer, Director | 97,344 | 0.09% | Dec 9, 2024 |
| Todd D. Macko | Chief Financial Officer | 155,122 | 0.14% | Mar 30, 2026 |
| Jason Grady | Director | 250,182 | 0.23% | Mar 25, 2026 |
| Heng Fai Ambrose Chan | Director | 0 | – | Apr 7, 2025 |
| Dss, Inc. | 10% owner | 589,518 | 0.55% | Sep 24, 2026 |
| Inc. Alset | 10% owner | 0 | – | Apr 4, 2025 |
| International Ltd Alset | 10% owner | 734,058 | 0.68% | Apr 4, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Dss, Inc. 10% owner | Sep 24, 2026 | Sale | −156 | $7.06 | $1.10K | 589,518 |
| Dss, Inc. 10% owner | Sep 23, 2026 | Sale | −27 | $6.95 | $188 | 589,674 |
| Dss, Inc. 10% owner | Sep 22, 2026 | Sale | −723 | $0.55 | $398 | 589,701 |
| Todd D. Macko Chief Financial Officer | Mar 27, 2026 | Sale | −43,400 | $0.56 | $24.30K | 155,122 |
| Todd D. Macko Chief Financial Officer | Mar 25, 2026 | Sale | −1,600 | $0.60 | $960 | 198,122 |
| Jason Grady Director | Mar 23, 2026 | Sale | −50,000 | $0.65 | $32.50K | 250,182 |
| Dss, Inc. 10% owner | May 27, 2025 | Sale | −45,400 | $0.54 | $24.52K | 545,024 |
| Dss, Inc. 10% owner | May 27, 2025 | Sale | −45,400 | $0.54 | $24.52K | 0 |
| Dss, Inc. 10% owner | May 22, 2025 | Sale | −115,600 | $0.55 | $63.58K | 590,424 |
| Dss, Inc. 10% owner | May 22, 2025 | Sale | −115,600 | $0.55 | $63.58K | 45,400 |
| Dss, Inc. 10% owner | Apr 4, 2025 | Sale | −890,800 | $0.95 | $846.26K | 161,100 |
| Inc. Alset 10% owner | Apr 4, 2025 | Sale | −180,000 | $0.96 | $172.80K | 0 |
| Heng Fai Ambrose Chan Director | Apr 3, 2025 | Sale | −351,555 | $0.50 | $175.78K | 0 |
| Inc. Alset 10% owner | Apr 3, 2025 | Sale | −273,286 | $0.78 | $213.16K | 180,000 |
| Inc. Alset 10% owner | Apr 3, 2025 | Sale | −351,631 | $0.58 | $203.95K | 0 |
| Inc. Alset 10% owner | Apr 2, 2025 | Sale | −382,427 | $0.58 | $221.81K | 351,631 |
| Inc. Alset 10% owner | Apr 2, 2025 | Sale | −2,349 | $0.67 | $1.57K | 351,555 |
| Inc. Alset 10% owner | Apr 2, 2025 | Sale | −200,000 | $0.67 | $134.00K | 353,904 |
| Inc. Alset 10% owner | Apr 2, 2025 | Sale | −300,000 | $0.58 | $174.00K | 553,904 |
| International Ltd Alset 10% owner | Apr 1, 2025 | Sale | −1,176,918 | $1.08 | $1.27M | 734,058 |
| International Ltd Alset 10% owner | Apr 1, 2025 | Sale | −650,000 | $1.45 | $942.50K | 1,910,976 |
| International Ltd Alset 10% owner | Apr 1, 2025 | Sale | −400,000 | $0.98 | $392.00K | 853,904 |
| International Ltd Alset 10% owner | Mar 31, 2025 | Sale | −300,000 | $1.03 | $309.00K | 1,253,904 |
| Dss, Inc. 10% owner | Mar 27, 2025 | Sale | −47,681 | $2.50 | $119.20K | 1,051,800 |
| Dss, Inc. 10% owner | Mar 26, 2025 | Sale | −9,858 | $3.15 | $31.05K | 1,099,481 |
| Dss, Inc. 10% owner | Mar 26, 2025 | Sale | −48,281 | $3.13 | $151.12K | 1,109,339 |
| Dss, Inc. 10% owner | Mar 21, 2025 | Sale | −166,600 | $3.30 | $549.78K | 1,178,882 |
| Dss, Inc. 10% owner | Mar 21, 2025 | Sale | −166,600 | $3.30 | $549.78K | 0 |
| Dss, Inc. 10% owner | Mar 21, 2025 | Sale | −166,600 | $3.30 | $549.78K | 0 |
| Dss, Inc. 10% owner | Mar 20, 2025 | Buy | +200 | $1.55 | $310 | 53,280 |
| Dss, Inc. 10% owner | Mar 20, 2025 | Sale | −53,280 | $4.68 | $249.35K | 0 |
| Frank D. Heuszel Chief Executive Officer, Director | Dec 5, 2024 | Buy | +500 | $2.26 | $1.13K | 97,344 |
| Dss, Inc. 10% owner | Dec 2, 2024 | Sale | −20 | $2.90 | $58 | 53,080 |
| Frank D. Heuszel Chief Executive Officer, Director | Nov 27, 2024 | Buy | +500 | $2.61 | $1.31K | 96,844 |
| Frank D. Heuszel Chief Executive Officer, Director | Nov 26, 2024 | Buy | +550 | $2.63 | $1.45K | 95,844 |
| Frank D. Heuszel Chief Executive Officer, Director | Nov 26, 2024 | Buy | +500 | $2.59 | $1.30K | 96,344 |
| Dss, Inc. 10% owner | Nov 18, 2024 | Sale | −5,000 | $3.02 | $15.10K | 53,100 |
| Dss, Inc. 10% owner | Nov 13, 2024 | Sale | −200 | $2.80 | $560 | 58,100 |
| Dss, Inc. 10% owner | Nov 12, 2024 | Sale | −500 | $2.76 | $1.38K | 58,300 |
| Dss, Inc. 10% owner | Sep 18, 2024 | Buy | +1,000 | $2.33 | $2.33K | 58,800 |
| Dss, Inc. 10% owner | Sep 17, 2024 | Buy | +7,800 | $2.40 | $18.72K | 57,800 |
| Dss, Inc. 10% owner | Sep 16, 2024 | Buy | +50,000 | $2.69 | $134.50K | 50,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.